(Q44273844)

English

MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 December 2017

MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients (English)

1 reference

Europe PubMed Central

1 December 2017

1 reference

based on heuristic

inferred from title

author name string

Radek Lakomy

1

1 reference

Europe PubMed Central

1 December 2017

Jiri Sana

2

1 reference

Europe PubMed Central

1 December 2017

Simona Hankeova

3

1 reference

Europe PubMed Central

1 December 2017

Pavel Fadrus

4

1 reference

Europe PubMed Central

1 December 2017

Leos Kren

5

1 reference

Europe PubMed Central

1 December 2017

Eva Lzicarova

6

1 reference

Europe PubMed Central

1 December 2017

Marek Svoboda

7

1 reference

Europe PubMed Central

1 December 2017

Hana Dolezelova

8

1 reference

Europe PubMed Central

1 December 2017

Martin Smrcka

9

1 reference

Europe PubMed Central

1 December 2017

Rostislav Vyzula

10

1 reference

Europe PubMed Central

1 December 2017

Jaroslav Michalek

11

1 reference

Europe PubMed Central

1 December 2017

Marian Hajduch

12

1 reference

Europe PubMed Central

1 December 2017

Ondrej Slaby

13

1 reference

Europe PubMed Central

1 December 2017

publication date

12 October 2011

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

102

1 reference

Europe PubMed Central

1 December 2017

2186-2190

1 reference

Europe PubMed Central

1 December 2017

12

1 reference

Europe PubMed Central

1 December 2017

Epidemiology and molecular pathology of glioma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

Genetic pathways to glioblastoma: a population-based study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

Oncomirs - microRNAs with a role in cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

MicroRNA involvement in glioblastoma pathogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

Immunohistochemical detection of HSP27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

Extensive modulation of a set of microRNAs in primary glioblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

A ten-microRNA expression signature predicts survival in glioblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02092.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2011.02092.X

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44273844&oldid=2109056778"